You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KRAS mutation

Showing 1 - 25 of 3,013
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Guangzhou (YL-17231)

Recruiting
  • Advanced Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 5, 2023

Each Codon-specific KRAS Mutation in Colorectal Cancer

Completed
  • Colorectal Cancer
  • Mutation
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Dec 10, 2022

Solid Tumors, KRAS Mutation Trial in Chiba, Kashiwa, Tokyo, Chuo-ku, Tokyo, Koto-ku (BI 3011441)

Completed
  • Solid Tumors, KRAS Mutation
  • BI 3011441
  • Chiba, Kashiwa, Japan
  • +2 more
Nov 11, 2022

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • Phoenix, Arizona
  • +6 more
Nov 10, 2022

Survival Status of KRAS Mutation Advanced Non-small Cell Lung

Enrolling by invitation
  • KRAS Gene Mutation Advanced Non-small Cell Lung Cancer
  • kras
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 1, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Solid Tumor, KRAS Mutation Trial (BI 3706674)

Not yet recruiting
  • Solid Tumor, KRAS Mutation
  • BI 3706674
  • (no location specified)
Sep 29, 2023

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023

Lung Cancer, NSCLC, PD-L1 Gene Mutation Trial in Detroit (Durvalumab, Carboplatin, Pemetrexed)

Withdrawn
  • Lung Cancer
  • +3 more
  • Detroit, Michigan
    Henry Ford Health System
Feb 15, 2022

NSCLC, KRAS Mutation-Related Tumors Trial in Philadelphia (Binimetinib Pill, Hydroxychloroquine Pill)

Recruiting
  • Non-Small Cell Lung Cancer
  • KRAS Mutation-Related Tumors
  • Binimetinib Pill
  • Hydroxychloroquine Pill
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 30, 2022

Non Small Cell Lung Cancer, Solid Tumor Trial in Fairfax (BBP-398 with nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • BBP-398 with nivolumab
  • Springdale, Arkansas
  • +6 more
Jan 27, 2023

Solid Tumors, KRAS Mutation; SOS1 Trial in Germany, Netherlands, United States (BI 1701963, Trametinib)

Active, not recruiting
  • Solid Tumors, KRAS Mutation; SOS1
  • Boston, Massachusetts
  • +7 more
Aug 22, 2022

Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)

Terminated
  • Metastatic Colorectal Cancer (CRC)
  • Shanghai, China
    Shanghai East Hospital, Tongji University China
Apr 19, 2022

Solid Tumors, KRAS Mutation Trial in Worldwide (BI 1823911, BI 1701963, Midazolam)

Recruiting
  • Solid Tumors, KRAS Mutation
  • BI 1823911
  • +2 more
  • New York, New York
  • +8 more
Aug 10, 2022

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Santa Rosa, California
    Providence Medical Foundation
May 2, 2023

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

Not yet recruiting
  • Solid Tumor
  • +4 more
  • (no location specified)
Feb 21, 2023

KRAS Mutation-Related Tumors, Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (TPX-0005, Trametinib)

Active, not recruiting
  • KRAS Mutation-Related Tumors
  • +2 more
  • Los Angeles, California
  • +5 more
Nov 7, 2022

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Amsterdam (RMC-4630, LY3214996)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • (no location specified)
Mar 9, 2022

Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

Recruiting
  • Advanced Solid Tumors
  • GEC255 tablets
  • Chengdu, Sichuan, China
    China West Hospital
Mar 14, 2023

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023